Grants per year
Personal profile
Research Interests
Crohn's disease and Ulcerative Colitis
Certifications and Licenses
| Gastroenterology | |
| Internal Medicine |
Training Experience
| 1978 | Internship, University of Chicago |
| 1980 | Residency, University of Chicago |
| 1982 | Fellowship, University of Chicago |
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1977
Research interests keywords
- Inflammatory Bowel Disease
Fingerprint
Dive into the research topics where stephen B Hanauer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #ABX464-105: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects with Moderately to Severely Active Ulcerative Colitis (ABTECT-1)
Hanauer, S. B. (PD/PI)
11/19/24 → 11/19/27
Project: Research project
-
Prot #1425-0003: A Phase IIa, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BI 706321 Orally Administered for 12 Weeks in Patients with Crohn`s Disease (CD) Receiving Ustekinu
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.
1/17/24 → 1/17/27
Project: Research project
-
Prot #IM047029: A Phase 4, Prospective, Open‐label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clinical Practice
Hanauer, S. B. (PD/PI)
PPD Investigator Services, LLC, Celgene International II Sàrl
9/25/23 → 9/25/26
Project: Research project
-
: Prot #78934804CRD2001: A Phase 2b Randomized, Double‐blind, Active‐ and Placebo‐controlled, Parallel‐ group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Partici
Hanauer, S. B. (PD/PI)
Parexel, Janssen Research & Development, LLC
6/12/23 → 8/24/28
Project: Research project
-
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
Bonner, L. B. (PD/PI), Bonner, L. B. (PD/PI), Dulai, P. S. (PD/PI), Dulai, P. S. (PD/PI), Hanauer, S. B. (Co-Investigator), Hanauer, S. B. (Co-Investigator), Hanauer, S. B. (Co-Investigator), Hirano, I. (Co-Investigator), Hirano, I. (Co-Investigator), Scholtens, D. M. (Co-Investigator), Scholtens, D. M. (Co-Investigator), Sumagin, R. (Co-Investigator), Sumagin, R. (Co-Investigator), Sumagin, R. (Co-Investigator), Yang, G.-Y. (Co-Investigator), Yang, G.-Y. (Co-Investigator) & Yang, G.-Y. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
3/15/23 → 2/29/28
Project: Research project
-
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine
Stanton, M. B., Solinski, M. A. & Hanauer, S. B., 2025, (Accepted/In press) In: Expert Review of Clinical Immunology.Research output: Contribution to journal › Review article › peer-review
-
Reply
Hanauer, S. B. & Colombel, J. F., Mar 2025, In: Gastroenterology. 168, 3, p. 631-632 2 p.Research output: Contribution to journal › Letter › peer-review
-
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis
Narula, N., Hamam, H., Liu, J., Wong, E. C. L., Marshall, J. K., Jairath, V., Hanauer, S. B., Reinisch, W. & Dulai, P. S., Nov 1 2024, In: Journal of Crohn's and Colitis. 18, 11, p. 1863-1869 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn’s Disease in the SERENE Studies
Verstockt, B., Pivorunas, V., Mahi, N. A., Smaoui, N., Guay, H., Kennedy, N. A., Goodhand, J. R., Lin, S., Bai, B. Y. H., Hanauer, S. B., Ferrante, M., Panés, J. & Vermeire, S., Apr 1 2024, In: Journal of Crohn's and Colitis. 18, 4, p. 493-505 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium
the HBOT-UC Consortium Investigators, Dec 2024, In: Alimentary Pharmacology and Therapeutics. 60, 11-12, p. 1512-1524 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations